| Gout patient hospitalizations: what’s causing the increase? |
|
|
|
|
| |
September 18, 2017 |
|
| |
|
| |
The latest Gout news from News Medical |
|
|
|
 | | |  Gout patient hospitalizations: what’s causing the increase? We looked at all hospitalizations in patients with gout. The concern is that gout is often considered as a disease of just the joints, specifically of the big toe. Yet, there have been quite a lot of studies that have talked about the many other comorbidities that occur because of hyperuricemia and gout. | | | | |  Kidney Stones - Nephrolithiasis Urine is composed of numerous dissolved salts and minerals. Higher levels of these salts and minerals in the urine may result in the formation of stones in the kidney (kidney stones)—scientifically termed as urolithiasis or nephrolithiasis. | |
|
|
|  | | | | |  Kidney Stones in Children Kidney stones are uncommon among children, yet in the last few years, the incidence of kidney stone in children has increased steadily. | |  | | | | |  Kidney Stone Diagnosis To diagnose kidney stones physicians ask patients about the symptoms and health conditions that could possibly promote stone formation in the kidneys, and review the patient’s medical history, family history of stone formation, and foods consumed. Laboratory and imaging tests are carried out after physical tests to diagnose the presence of kidney stones. | | | | | | |  Kidney Stones: Symptoms and Causes Kidney stones are often asymptotic and cause no noticeable signs, which makes them difficult to diagnose. However, when the stone travels from the kidney to the bladder, it may get caught in the ureter. The stone can block urine flow from the kidney and cause swelling, discomfort and pain to affected individuals. Although there is no single or definite cause, there are quite a few factors that can heighten the risk of stone formation. | |
|
|
| | | |  Waking up in the morning with the joint pain, swelling and stiffness that accompanies lupus doesn't exactly inspire a workout. | | | | |  On the 13th of September 2017, a U.S. Food and Drug Administration (FDA) advisory panel has voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix is on its way to FDA approval. | |
|
|
|
|
|
|
|
